RP-HPLC Method for Determination of Oseltamivir Phosphate in Capsules and Spiked Plasma

REFERENCES

• Abdel-Wadood , H. M. , N. A. Mohamed , and A. M. Mahmoud . 2008 . Validated spectrofluorometric methods for determination of amlodipine besylate in tablets . Spectrochim. Acta A Mol. Biomol. Spectrosc. 70 : 564 – 570 .
   PubMed Web of Science ®Google Scholar
• Aydoğmuş , Z. 2009 . Simple and sensitive spectrofluorimetric method for the determination of oseltamivir phosphate in capsules through derivatization with fluorescamine . J. Fluoresc. 19 : 673 – 679 .
   PubMed Web of Science ®Google Scholar
• Bahrami , G. , B. Mohammadi , and A. Kiani . 2008 . Determination of oseltamivir carboxylic acid in human serum by solid phase extraction and high performance liquid chromatography with UV detection . J. Chromatogr. B 864 : 38 – 42 .
   PubMed Web of Science ®Google Scholar
• British Pharmacopoeia . 1998 . London: Her Majesty's Stationery Office. pp. 799–800.
   Google Scholar
• Eisenberg , E. J. , and K. C. Cundy . 1998 . High-performance liquid chromatographic determination of GS4071, a potent inhibitor of influenza neuraminidase, in plasma by precolumn fluorescence derivatization with naphthalenedialdehyde . J. Chromatogr. B 716 : 267 – 273 .
   PubMedGoogle Scholar
• Fuke , C. , Y. Ihama , and T. Miyazaki . 2008 . Analysis of oseltamivir active metabolite, oseltamivir carboxylate, in biological materials by HPLC-UV in a case of death following ingestion of Tamiflu . Legal Med. 10 : 83 – 87 .
   PubMedGoogle Scholar
• Green , M. D. , H. Nettey , and R. A. Wirtz . 2008 . Determination of oseltamivir quality by colorimetric and liquid chromatographic methods . Emerg. Infect. Dis. 14 : 552 – 556 .
   PubMed Web of Science ®Google Scholar
• Gubareva , L. V. , L. Kaiser , and F. G. Hayden . 2000 . Influenza virus neuraminidase inhibitors . Lancet 355 : 827 – 835 .
   PubMed Web of Science ®Google Scholar
• ICH. 1996. Harmonized Tripartite Guideline: Validation of Analytical Procedures, Methodology Having Reached Step 4 of the ICH Process at the ICH Steering Committee Meeting on, November 6.
   Google Scholar
• Jabbaribar , F. , A. Mortazavi , R. Jalali-Milani , and A. Jouyban . 2008 . Analysis of oseltamivir in Tamiflu capsules using micellar electrokinetic chromatography . Chem. Pharm. Bull. 56 : 1639 – 1644 .
   PubMed Web of Science ®Google Scholar
• Joseph-Charles , J. , C. Geneste , E. Laborde-Kummer , R. Gheyouche , H. Boudis , and J. P. Dubost . 2007 . Development and validation of a rapid HPLC method for the determination of oseltamivir phosphate in Tamiflu and generic versions . J. Pharm. Biomed. Anal. 44 : 1008 – 1013 .
   PubMed Web of Science ®Google Scholar
• Li , W. , P. A. Escarpe , E. J. Eisenberg , K. C. Cundy , C. Sweet , K. J. Jakeman , et al. . 1998 . Identification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071 . Antimicrob. Agents Chemother. 42 : 647 – 653 .
   PubMed Web of Science ®Google Scholar
• Lindegårdh , N. , T. T. Hien , J. Farrar , P. Singhasivanon , N. J. White , and N. P. Day . 2006 . A simple and rapid liquid chromatographic assay for evaluation of potentially counterfeit Tamiflu . J. Pharm. Biomed. Anal. 42 : 430 – 433 .
   PubMed Web of Science ®Google Scholar
• Lindegårdh , N. , W. Hanpithakpong , Y. Wattanagoon , P. Singhasivanon , N. J. White , and N. P. Day . 2007 . Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of oseltamivir and its metabolite oseltamivir carboxylate in plasma, saliva and urine . J. Chromatogr. B 859 : 74 – 83 .
   PubMed Web of Science ®Google Scholar
• McClellan , K. , and C. M. Perry . 2001 . Oseltamivir: A Review of its use in influenza . Drugs 61 : 263 – 283 .
   PubMed Web of Science ®Google Scholar
• Narasimhan , B. , K. Abida , and K. Srinivas . 2008 . Stability indicating RP-HPLC method development and validation for oseltamivir API . Chem. Pharm. Bull. 56 : 413 – 417 .
   PubMed Web of Science ®Google Scholar
• Nicholson , K. G. , F. Y. Aoki , A. D. Osterhaus , S. Trottier , O. Carewicz , C. H. Mercier , A. Rode , N. Kinnersley , and P. Ward . 2000 . Efficacy and safety of oseltamivir in treatment of acute influenza: A randomised controlled trial . Lancet 355 : 1845 – 1850 .
   PubMed Web of Science ®Google Scholar
• Wiltshire , H. , B. Wiltshire , A. Citron , T. Clarke , C. Serpe , D. Gray , and W. Herron . 2000 . Development of a high-performance liquid chromatographic-mass spectrometric assay for the specific and sensitive quantification of Ro 64-0802, an anti-influenza drug, and its pro-drug, oseltamivir, in human and animal plasma and urine . J. Chromatogr. B 745 : 373 – 388 .
   PubMed Web of Science ®Google Scholar